Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis

Maggie L Naguib1, Iris Schrijver, Phyllis Gardner

  • 1Department of Pediatrics, Division of Pulmonology, Cairo University Children's Hospital, Faculty of Medicine Cairo, Egypt.

Insights

Cystic Fibrosis (CF) is more common in Egyptian children than previously thought, with 20% of screened patients testing positive. Genetic analysis identified eight CFTR sequence changes, highlighting the need for further research into CF's prevalence and genetic causes in Egypt.

Area of Science:

  • Medical Genetics
  • Pediatric Pulmonology
  • Genetic Epidemiology

Background:

  • Limited data exists on Cystic Fibrosis (CF) prevalence in Egypt.
  • CF is a genetic disorder affecting multiple organs, primarily the lungs and digestive system.
  • Early diagnosis and genetic understanding are crucial for effective management.

Purpose of the Study:

  • To screen Egyptian children with clinical symptoms suggestive of CF.
  • To identify the genetic mutations responsible for CF in this population.
  • To assess the potential underestimation of CF incidence in Egypt.

Main Methods:

  • Sixty-one pediatric patients with relevant symptoms were enrolled.
  • Sweat testing was performed, followed by quantitative sweat testing for positive cases.
  • DNA sequencing of the CFTR gene was conducted on affected individuals and a sibling.

Main Results:

  • Twelve out of 61 patients (20%) showed positive results on initial sweat chloride screening.
  • Quantitative sweat testing confirmed positive results in 10 patients.
  • Eight distinct CFTR sequence variations were identified in seven probands and one sibling.

Conclusions:

  • Cystic Fibrosis appears to be more prevalent in Egypt than previously recognized.
  • Further extensive studies are needed to determine the true incidence and genetic landscape of CF in Egypt.
  • Understanding the molecular basis and clinical patterns of CF in Egypt is essential for public health initiatives.
Abstract